Malaria, Diabetes, Teen Health: The Week in Health

This week’s health news highlights key advances in public health, from Mexico’s ongoing progress in malaria elimination to promising results from Eli Lilly’s Phase 3 trial of an oral diabetes treatment. Meanwhile, researchers have identified rare lung cells that play a crucial role in controlling COVID-19 inflammation, and the WHO has issued new guidelines aimed at reducing adolescent pregnancy by improving education, healthcare access, and legal protections for girls.

This is The Week in Health!

Mexico Advances Malaria Elimination as Global Efforts Expand

The Pan American Health Organization (PAHO) and Mexico’s Ministry of Health (SSa) highlighted the advances and ongoing challenges in the fight against malaria, as efforts intensify to achieve its elimination in the Americas.

Eli Lilly’s Oral Diabetes Drug Shows Promise in Phase 3 Trial

Eli Lilly reports positive topline results from a Phase 3 clinical trial of orforglipron, its investigational once-daily oral medication for adults with type 2 diabetes who are not achieving glycemic control with diet and exercise alone.

Rare Lung Cells Shown to Control COVID-19 Inflammation

A rare class of immune cells in the lungs plays a critical role in controlling the body’s inflammatory response to COVID-19, according to a new study led by researchers at NYU Langone Health. Published April 25 in Immunity, the study found that nerve and airway-associated interstitial macrophages (NAM) are essential for survival during infection with SARS-CoV-2.

WHO Issues New Guidelines to Curb Adolescent Pregnancy

WHO released updated guidelines aimed at reducing adolescent pregnancies, with a focus on ending child marriage, expanding access to education, and improving sexual and reproductive health services for girls. “Early pregnancies can have serious physical and psychological consequences for girls and young women,” says Pascale Allotey, Director of Sexual and Reproductive Health and Research, WHO. 

Views From Top

We invite you to read this week’s interviews with top healthcare leaders, including: 

• A Hybrid Approach to Healthcare in Latin America - José Joaquín Mora, Founding Partner, Farmalisto

• Empowering Small Hospitals with Technology, Specialized Solutions - Jorge Camargo, President, Ecaresoft

• Prevention Programs Strengthen Workplace Wellness - Tayde Prida, General Director, Grupo Consulmed